Votrient (pazopanib) 400 mg, 30 tablets, Novartis, original Votrient (pazopanib) is used for advanced renal cell carcinoma. International medicine delivery within 4-5 days with storage conditions maintained. Payment on delivery.
Delivery methods
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
Payment methods
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Votrient Pazopanib is an antitumor drug, a tyrosine kinase inhibitor for oral administration.
Votrient (Pazopanib) is used to treat advanced renal cell carcinoma (RCC), the treatment of advanced soft tissue sarcoma (except gastrointestinal stromal tumors and liposarcoma) in patients who have previously received chemotherapy.
Pazopanib is an inhibitor of multiple tyrosine kinases, incl. tyrosine kinase endothelial growth factor receptor-1, -2, -3 (VEGFR-1, VEGFR-2, VEGFR-3), platelet-derived growth factor receptor alpha and beta (PDGFR-? and PDGFR-?), fibroblast growth factor receptor-1 and -3 (FGFR-1, -3).
No reviews yet
